These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2516396)

  • 1. Protection against pertussis by acellular pertussis vaccines (Takeda, Japan): household contact studies in Kawasaki City, Japan.
    Kato T; Goshima T; Nakajima N; Kaku H; Arimoto Y; Hayashi F
    Acta Paediatr Jpn; 1989 Dec; 31(6):698-701. PubMed ID: 2516396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against pertussis by Takeda's acellular pertussis vaccine: household contact studies in Kawasaki City, Japan.
    Kato T; Kaku H; Arimoto Y
    Tokai J Exp Clin Med; 1988; 13 Suppl():35-8. PubMed ID: 3078808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protection against pertussis by Japanese T type acellular pertussis vaccine: household contact study in Kawasaki City].
    Kato T; Matsuyoshi S; Goshima T; Nakajima N; Yamamoto H; Arimoto Y; Kaku H; Hayashi F
    Kansenshogaku Zasshi; 1989 Sep; 63(9):986-90. PubMed ID: 2509597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and immunogenicity of acellular pertussis vaccine by manufacturer and patient age.
    Aoyama T; Murase Y; Kato M; Iwai H; Iwata T
    Am J Dis Child; 1989 Jun; 143(6):655-9. PubMed ID: 2471406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type-specific efficacy of acellular pertussis vaccine.
    Aoyama T; Murase Y; Gonda T; Iwata T
    Am J Dis Child; 1988 Jan; 142(1):40-2. PubMed ID: 2893537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of currently available Japanese acellular pertussis vaccines and future problems.
    Kamiya H; Nii R
    Tokai J Exp Clin Med; 1988; 13 Suppl():45-9. PubMed ID: 3273618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical studies on efficacy and safety of acellular pertussis vaccine.
    Isomura S
    Tokai J Exp Clin Med; 1988; 13 Suppl():39-43. PubMed ID: 3078809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary report on household contact studies of the prevention of pertussis in Japanese children by Takeda diphtheria and tetanus toxoids and acellular pertussis vaccine combined.
    Mortimer EA
    Tokai J Exp Clin Med; 1988; 13 Suppl():29-34. PubMed ID: 3078807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan.
    Kuno-Sakai H; Kimura M; Watanabe H
    Biologicals; 2004 Mar; 32(1):29-35. PubMed ID: 15026023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children.
    Mortimer EA; Kimura M; Cherry JD; Kuno-Sakai H; Stout MG; Dekker CL; Hayashi R; Miyamoto Y; Scott JV; Aoyama T
    Am J Dis Child; 1990 Aug; 144(8):899-904. PubMed ID: 2378338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of a monovalent, multicomponent acellular pertussis vaccine in 15 month-6-year-old German children. Monovalent Acellular Pertussis Vaccine Study Group.
    Stehr K; Heininger U; Uhlenbusch R; Angersbach P; Hackell J; Eckhardt T
    Eur J Pediatr; 1995 Mar; 154(3):209-14. PubMed ID: 7758519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists.
    Noble GR; Bernier RH; Esber EC; Hardegree MC; Hinman AR; Klein D; Saah AJ
    JAMA; 1987 Mar; 257(10):1351-6. PubMed ID: 3820444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of acellular pertussis vaccine in Aichi Prefecture, Japan.
    Isomura S
    Pediatr Infect Dis J; 1988 Apr; 7(4):258-62. PubMed ID: 3368258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization.
    Kuno-Sakai H; Kimura M
    Pediatr Int; 2004 Dec; 46(6):650-5. PubMed ID: 15660862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pertussis Vaccine Study Group.
    Heininger U; Cherry JD; Stehr K; Schmitt-Grohé S; Uberall M; Laussucq S; Eckhardt T; Meyer M; Gornbein J
    Pediatrics; 1998 Sep; 102(3 Pt 1):546-53. PubMed ID: 9738175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies on efficacy and safety of an acellular pertussis vaccine in Aichi Prefecture, Japan.
    Isomura S
    Dev Biol Stand; 1991; 73():37-42. PubMed ID: 1778331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
    Sato Y; Sato H
    Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rate of vaccine failure after administration of acellular pertussis vaccine pre- and post-liver transplantation in children at a children's hospital in Japan.
    Ito K; Kasahara M; Saitoh A; Honda H; Miyairi I
    Transpl Infect Dis; 2016 Feb; 18(1):150-4. PubMed ID: 26565897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculation of efficacy of acellular pertussis vaccine from the number of pertussis patients and vaccinees in three areas.
    Ohkuni H; Yabiku M; Togawa M; Fukai K; Yosida I; Minekawa Y; Kitamura T
    Dev Biol Stand; 1991; 73():43-9. PubMed ID: 1778332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.